Satoshi Tashiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Satoshi Tashiro has a total of 201 co-authors. Here are the top co-authors by number of shared publications:
Jiying Sun
Department of Cellular Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University
16 shared publicationsYasunori Horikoshi
Department of Cellular Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
10 shared publicationsLin Shi
Department of Radiology, The Second Affiliated Hospital of Shandong First Medical University, Tai’an, China
7 shared publicationsChiemi Sakai
Department of Cardiovascular Physiology and Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University
5 shared publicationsHiroki Shima
Tohoku University School of Medicine
5 shared publicationsTsuyoshi Ikura
Kyoto University
5 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- p. 1-15
Developmental age determines DNA damage response dynamics and tumor susceptibility following irradiation in the small intestine of Apc Min/+ mice
- 17 November 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- p. 1-15
Open AccessDevelopmental age determines DNA damage response dynamics and tumor susceptibility following irradiation in the small intestine of Apc Min/+ mice
- Open Access
- 7 August 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1888108
Exploratory assessment of the potential protective effects of Kampo treatment against low dose medical radiation: a single arm prospective observational study
Introduction: Low-dose computed tomography (CT) scans can induce DNA damage, including chromosomal aberrations (CAs) and DNA double-strand breaks, which may contribute to long-term cancer risk. D-limonene, a bioactive component present in several Kampo formulas, has shown radioprotective effects in preclinical studies; however, clinical evidence remains limited, and the gastrointestinal side effects associated with isolated D-limonene may restrict its clinical application. This single-arm observational pilot study aimed to evaluate whether Kampo formulas containing D-limonene could mitigate CT-induced cytogenetic damage and to generate preliminary data for designing a future definitive trial. Methods: Thirty-nine patients with functional dyspepsia received one of four D-limonene-containing Kampo formulas: bukuryoin, rikkunshito, heiisan, or nichinto. Peripheral blood lymphocytes were collected before and after Kampo treatment and exposed in vitro to CT radiation. Chromosomal aberrations were assessed using peptide nucleic acid fluorescence in situ hybridization (PNA-FISH), while DNA double-strand breaks were evaluated by γ-H2AX immunofluorescence. Wilcoxon signed-rank tests and linear mixedeffects models were used to assess radiation effects and Kampo-related interactions, and intraclass correlation coefficients (ICCs) were calculated to compare assay reliability. Results: CT exposure significantly increased CAs before Kampo treatment (p = 0.024), whereas this increase was attenuated after treatment (p = 0.417). However, neither the pre–post difference-in-differences analysis (p = 0.428) nor the CT × Kampo interaction in the mixed-effects model (β = –0.72; 95% CI, –2.19 to 0.75; p = 0.343) reached statistical significance. γ-H2AX showed a similar trend. PNA-FISH demonstrated higher measurement reliability than γ-H2AX immunofluorescence (ICC = 0.89 vs. 0.65). Sample size estimation based on PNA-FISH indicated that 275–295 evaluable participants per arm would be required for a future definitive trial. Discussion: Overall, Kampo formulas containing D-limonene showed a trend toward mitigating CT-induced cytogenetic injury, and PNA-FISH appeared to provide a more reliable endpoint than γ-H2AX. These exploratory findings support further investigation in a randomized controlled trial to determine whether D-limonene-containing Kampo formulas can meaningfully mitigate CT-associated genotoxicity in humans.
- 7 August 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1888108
Open AccessExploratory assessment of the potential protective effects of Kampo treatment against low dose medical radiation: a single arm prospective observational study
Introduction: Low-dose computed tomography (CT) scans can induce DNA damage, including chromosomal aberrations (CAs) and DNA double-strand breaks, which may contribute to long-term cancer risk. D-limonene, a bioactive component present in several Kampo formulas, has shown radioprotective effects in preclinical studies; however, clinical evidence remains limited, and the gastrointestinal side effects associated with isolated D-limonene may restrict its clinical application. This single-arm observational pilot study aimed to evaluate whether Kampo formulas containing D-limonene could mitigate CT-induced cytogenetic damage and to generate preliminary data for designing a future definitive trial. Methods: Thirty-nine patients with functional dyspepsia received one of four D-limonene-containing Kampo formulas: bukuryoin, rikkunshito, heiisan, or nichinto. Peripheral blood lymphocytes were collected before and after Kampo treatment and exposed in vitro to CT radiation. Chromosomal aberrations were assessed using peptide nucleic acid fluorescence in situ hybridization (PNA-FISH), while DNA double-strand breaks were evaluated by γ-H2AX immunofluorescence. Wilcoxon signed-rank tests and linear mixedeffects models were used to assess radiation effects and Kampo-related interactions, and intraclass correlation coefficients (ICCs) were calculated to compare assay reliability. Results: CT exposure significantly increased CAs before Kampo treatment (p = 0.024), whereas this increase was attenuated after treatment (p = 0.417). However, neither the pre–post difference-in-differences analysis (p = 0.428) nor the CT × Kampo interaction in the mixed-effects model (β = –0.72; 95% CI, –2.19 to 0.75; p = 0.343) reached statistical significance. γ-H2AX showed a similar trend. PNA-FISH demonstrated higher measurement reliability than γ-H2AX immunofluorescence (ICC = 0.89 vs. 0.65). Sample size estimation based on PNA-FISH indicated that 275–295 evaluable participants per arm would be required for a future definitive trial. Discussion: Overall, Kampo formulas containing D-limonene showed a trend toward mitigating CT-induced cytogenetic injury, and PNA-FISH appeared to provide a more reliable endpoint than γ-H2AX. These exploratory findings support further investigation in a randomized controlled trial to determine whether D-limonene-containing Kampo formulas can meaningfully mitigate CT-associated genotoxicity in humans.
- Open Access
- 17 July 2026
- Published by Springer Nature in European Radiology
- Vol. 36 (11) , 8264-8276
Biological effects of 18F-FDG administration and CT dose during PET/CT: chromosomal aberrations in a two-center prospective observational study
Objective: To assess the radiation effects of internal 18 F-fluorodeoxyglucose (FDG) administration and external CT exposures during PET/CT, using reduced-dose and standard-dose CT protocols, on chromosomes in peripheral blood lymphocytes (PBLs). Materials and methods: This prospective two-center observational study included patients undergoing clinically indicated FDG-PET/CT using different CT dose protocols. Peripheral blood was sampled at three time points: before FDG administration, after FDG administration, and after CT acquisition. Unstable chromosomal aberrations (CAs) in PBLs were quantified at each time point. Non-parametric tests were used for group comparisons, and associations between radiation dose parameters and changes in CAs were evaluated using generalized linear mixed-effects models. Results: A total of 101 consecutive patients were enrolled in the reduced-dose protocol center (Center RD; mean age 70 ± 9 years [standard deviation], 55 men) and 56 patients in the standard-dose protocol center (Center SD; 64 ± 11 years, 31 men). The CA-evaluable population comprised 101 patients in Center RD and 55 patients in Center SD. FDG administration did not significantly increase CAs at either center. Following CT acquisition, no significant increase in CAs was observed with the reduced-dose protocol, whereas CAs increased significantly with the standard-dose protocol (Center SD: p = 0.016). Conclusion: FDG administration had no detectable impact on CAs, whereas CT effective dose was associated with CA frequency after multivariable adjustment, with no evidence of a synergistic interaction with FDG. These findings support CT dose optimization and the use of reduced-dose CT protocols in PET/CT when clinically appropriate. Key Points: Question How do internal 18F-fluorodeoxyglucose (FDG) and external CT exposures during PET/CT affect chromosomes, and how do these effects differ between reduced- and standard-dose CT protocols? Findings Chromosomal aberrations increased after standard-dose PET/CT, and CT effective dose, but not FDG effective dose, was independently associated with chromosomal aberration frequency after multivariable adjustment . Clinical relevance CT effective dose was independently associated with chromosomal aberration frequency, while age and prior chemotherapy also influenced CA frequency. This provides biological justification for CT dose optimization and broader use of reduced-dose PET/CT when clinically appropriate .
- 17 July 2026
- Published by Springer Nature in European Radiology
- Vol. 36 (11) , 8264-8276
Open AccessBiological effects of 18F-FDG administration and CT dose during PET/CT: chromosomal aberrations in a two-center prospective observational study
Objective: To assess the radiation effects of internal 18 F-fluorodeoxyglucose (FDG) administration and external CT exposures during PET/CT, using reduced-dose and standard-dose CT protocols, on chromosomes in peripheral blood lymphocytes (PBLs). Materials and methods: This prospective two-center observational study included patients undergoing clinically indicated FDG-PET/CT using different CT dose protocols. Peripheral blood was sampled at three time points: before FDG administration, after FDG administration, and after CT acquisition. Unstable chromosomal aberrations (CAs) in PBLs were quantified at each time point. Non-parametric tests were used for group comparisons, and associations between radiation dose parameters and changes in CAs were evaluated using generalized linear mixed-effects models. Results: A total of 101 consecutive patients were enrolled in the reduced-dose protocol center (Center RD; mean age 70 ± 9 years [standard deviation], 55 men) and 56 patients in the standard-dose protocol center (Center SD; 64 ± 11 years, 31 men). The CA-evaluable population comprised 101 patients in Center RD and 55 patients in Center SD. FDG administration did not significantly increase CAs at either center. Following CT acquisition, no significant increase in CAs was observed with the reduced-dose protocol, whereas CAs increased significantly with the standard-dose protocol (Center SD: p = 0.016). Conclusion: FDG administration had no detectable impact on CAs, whereas CT effective dose was associated with CA frequency after multivariable adjustment, with no evidence of a synergistic interaction with FDG. These findings support CT dose optimization and the use of reduced-dose CT protocols in PET/CT when clinically appropriate. Key Points: Question How do internal 18F-fluorodeoxyglucose (FDG) and external CT exposures during PET/CT affect chromosomes, and how do these effects differ between reduced- and standard-dose CT protocols? Findings Chromosomal aberrations increased after standard-dose PET/CT, and CT effective dose, but not FDG effective dose, was independently associated with chromosomal aberration frequency after multivariable adjustment . Clinical relevance CT effective dose was independently associated with chromosomal aberration frequency, while age and prior chemotherapy also influenced CA frequency. This provides biological justification for CT dose optimization and broader use of reduced-dose PET/CT when clinically appropriate .
- Open Access
- 29 May 2026
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 67 (4) , 556-567
Radiation effects of a CT scan on chromosomal aberrations in cancer and non-cancer patients
Computed tomography (CT) is indispensable in clinical practice, but the health risks of repeated low-dose radiation exposure remain unclear, especially in relation to potential differences between cancer and non-cancer patients. This study aimed to examine potential differences in biological responses to CT-associated low-dose irradiation between non-cancer patients and patients with hepatocellular carcinoma (HCC). In a prospective observational study, chromosomal aberrations (CAs) in peripheral blood lymphocytes (PBLs) were quantified by fluorescence in situ hybridization analysis with peptide nucleic acid probes (PNA-FISH). Data from 60 non-cancer patients obtained in our previous study were used as control, and 61 HCC patients were newly enrolled. Baseline CA frequencies were significantly higher in HCC patients (30.6 per 1000 cells) than in non-cancer patients (5.6 per 1000 cells; P < 0.0001). Among the 61 HCC patients, those with a history of radiotherapy (RT) exhibited higher baseline CAs (64.8 per 1000 cells) compared with those without RT (n = 49; 22.2 per 1000 cells). In RT-negative HCC patients, a history of TACE also correlated with increased baseline CAs (P < 0.05), suggesting a contribution of prior genotoxic therapies. In HCC patients without prior RT, a history of TACE also correlated with increased baseline CAs (P < 0.05), suggesting a contribution of prior genotoxic therapies. In addition, Notably, CT-induced CA formation was greater in HCC patients with prior RT than in patients without RT (P < 0.05). These results support careful assessment of cumulative medical radiation exposure in cancer patients who undergo repeated imaging and/or treatment.
- 29 May 2026
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 67 (4) , 556-567
Open AccessRadiation effects of a CT scan on chromosomal aberrations in cancer and non-cancer patients
Computed tomography (CT) is indispensable in clinical practice, but the health risks of repeated low-dose radiation exposure remain unclear, especially in relation to potential differences between cancer and non-cancer patients. This study aimed to examine potential differences in biological responses to CT-associated low-dose irradiation between non-cancer patients and patients with hepatocellular carcinoma (HCC). In a prospective observational study, chromosomal aberrations (CAs) in peripheral blood lymphocytes (PBLs) were quantified by fluorescence in situ hybridization analysis with peptide nucleic acid probes (PNA-FISH). Data from 60 non-cancer patients obtained in our previous study were used as control, and 61 HCC patients were newly enrolled. Baseline CA frequencies were significantly higher in HCC patients (30.6 per 1000 cells) than in non-cancer patients (5.6 per 1000 cells; P < 0.0001). Among the 61 HCC patients, those with a history of radiotherapy (RT) exhibited higher baseline CAs (64.8 per 1000 cells) compared with those without RT (n = 49; 22.2 per 1000 cells). In RT-negative HCC patients, a history of TACE also correlated with increased baseline CAs (P < 0.05), suggesting a contribution of prior genotoxic therapies. In HCC patients without prior RT, a history of TACE also correlated with increased baseline CAs (P < 0.05), suggesting a contribution of prior genotoxic therapies. In addition, Notably, CT-induced CA formation was greater in HCC patients with prior RT than in patients without RT (P < 0.05). These results support careful assessment of cumulative medical radiation exposure in cancer patients who undergo repeated imaging and/or treatment.
- Open Access
- 24 February 2026
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 67 (2) , 318-326
Development and clinical application of biological dosimetry technology: insights from the HICARE/IAEA 2025 international training course
The HICARE/IAEA 2025 International Training Course on Biological and Internal Dosimetry, held at Hiroshima University from 10 to 14 February 2025, convened 20 participants from nine countries— Brazil, Indonesia, Japan, Korea, the Philippines, Singapore, Thailand, the United States, and Vietnam—and was jointly organized by the Hiroshima International Council for Health Care of the Radiation-Exposed (HICARE) and the International Atomic Energy Agency (IAEA). With guidance from 13 expert lecturers, the course aimed to enhance global capacity in radiation dose assessment and clinical application of biodosimetry. The program, led by Prof. Satoshi Tashiro (HICARE) and Dr. Oleg Belyakov (IAEA), included lectures on cytogenetic assays, molecular biomarkers, and internal dosimetry using biokinetic modeling and bioassay data. Key themes emphasized the integration of biodosimetry into clinical decision-making, emergency preparedness, and occupational health monitoring. Discussions highlighted the expanding role of biodosimetry in complementing internal dose assessments for patients undergoing diagnostic imaging procedures—such as CT scans and nuclear medicine—as well as for individuals affected by radiological accidents. These sessions underscored the need for harmonized protocols, reliable dose reconstruction methods, and cross-institutional networks to support accurate and timely biodosimetric evaluations in both clinical and emergency settings. The workshop not only had advanced technical competencies but also positioned biodosimetry as a critical tool in global radiological protection strategies. Strong participant engagement and interest in future events reflected the course’s impact on strengthening international cooperation and translating research into practice.
- 24 February 2026
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 67 (2) , 318-326
Open AccessDevelopment and clinical application of biological dosimetry technology: insights from the HICARE/IAEA 2025 international training course
The HICARE/IAEA 2025 International Training Course on Biological and Internal Dosimetry, held at Hiroshima University from 10 to 14 February 2025, convened 20 participants from nine countries— Brazil, Indonesia, Japan, Korea, the Philippines, Singapore, Thailand, the United States, and Vietnam—and was jointly organized by the Hiroshima International Council for Health Care of the Radiation-Exposed (HICARE) and the International Atomic Energy Agency (IAEA). With guidance from 13 expert lecturers, the course aimed to enhance global capacity in radiation dose assessment and clinical application of biodosimetry. The program, led by Prof. Satoshi Tashiro (HICARE) and Dr. Oleg Belyakov (IAEA), included lectures on cytogenetic assays, molecular biomarkers, and internal dosimetry using biokinetic modeling and bioassay data. Key themes emphasized the integration of biodosimetry into clinical decision-making, emergency preparedness, and occupational health monitoring. Discussions highlighted the expanding role of biodosimetry in complementing internal dose assessments for patients undergoing diagnostic imaging procedures—such as CT scans and nuclear medicine—as well as for individuals affected by radiological accidents. These sessions underscored the need for harmonized protocols, reliable dose reconstruction methods, and cross-institutional networks to support accurate and timely biodosimetric evaluations in both clinical and emergency settings. The workshop not only had advanced technical competencies but also positioned biodosimetry as a critical tool in global radiological protection strategies. Strong participant engagement and interest in future events reflected the course’s impact on strengthening international cooperation and translating research into practice.
- Open Access
- 16 December 2024
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 65 (Supplement) , i1
Radiation medicine from the perspective of radiation disaster medical science research
- 16 December 2024
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 65 (Supplement) , i1
Open AccessRadiation medicine from the perspective of radiation disaster medical science research
- Open Access
- 12 January 2023
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 173 (5) , 375-382
Klotho protects chromosomal DNA from radiation-induced damage
Klotho is an anti-aging, single-pass transmembrane protein found mainly in the kidney. Although aging is likely to be associated with DNA damage, the involvement of Klotho in protecting cells from DNA damage is still unclear. In this study, we examined DNA damage in human kidney cells and mouse kidney tissue after ionizing radiation (IR). The depletion and overexpression of Klotho in human kidney cells reduced and increased the cell survival rates after IR, respectively. The formation of γ-H2AX foci, representing DNA damage, was significantly elevated immediately after IR in cells with Klotho depletion and decreased in cells overexpressing Klotho. These results were confirmed in mouse renal tissues after IR. Quantification of DNA damage by a comet assay revealed that the Klotho knockdown significantly increased the amount of DNA damage immediately after IR, suggesting that Klotho protects chromosomal DNA from the induction of damage, rather than facilitating DNA repair. Consistent with this notion, Klotho was detected in both the nucleus and cytoplasm. In the nucleus, Klotho may serve to protect chromosomal DNA from damage, leading to its anti-aging effects.
- 12 January 2023
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 173 (5) , 375-382
Open AccessKlotho protects chromosomal DNA from radiation-induced damage
Klotho is an anti-aging, single-pass transmembrane protein found mainly in the kidney. Although aging is likely to be associated with DNA damage, the involvement of Klotho in protecting cells from DNA damage is still unclear. In this study, we examined DNA damage in human kidney cells and mouse kidney tissue after ionizing radiation (IR). The depletion and overexpression of Klotho in human kidney cells reduced and increased the cell survival rates after IR, respectively. The formation of γ-H2AX foci, representing DNA damage, was significantly elevated immediately after IR in cells with Klotho depletion and decreased in cells overexpressing Klotho. These results were confirmed in mouse renal tissues after IR. Quantification of DNA damage by a comet assay revealed that the Klotho knockdown significantly increased the amount of DNA damage immediately after IR, suggesting that Klotho protects chromosomal DNA from the induction of damage, rather than facilitating DNA repair. Consistent with this notion, Klotho was detected in both the nucleus and cytoplasm. In the nucleus, Klotho may serve to protect chromosomal DNA from damage, leading to its anti-aging effects.
- Open Access
- 10 October 2022
- Published by Japan College of Angiology in The Journal of Japanese College of Angiology
- Vol. 62 (10) , 97-104
Cardiovascular Diseases and Medical Diagnostic Radiation Exposure
生活習慣病の増加と高齢化により動脈硬化症に関連した心血管疾患が増加している。心血管疾患の診断に不可欠なCTやカテーテル検査はX線照射を用いるため,患者のみならず,医療従事者の放射線被ばくの影響も考慮する必要がある。本稿では,放射線の人体に対する影響やその生物学的線量評価法について概説し,放射線が実際にどの程度患者や術者に生物学的影響を与えているのかを論じる。
- 10 October 2022
- Published by Japan College of Angiology in The Journal of Japanese College of Angiology
- Vol. 62 (10) , 97-104
Open AccessCardiovascular Diseases and Medical Diagnostic Radiation Exposure
生活習慣病の増加と高齢化により動脈硬化症に関連した心血管疾患が増加している。心血管疾患の診断に不可欠なCTやカテーテル検査はX線照射を用いるため,患者のみならず,医療従事者の放射線被ばくの影響も考慮する必要がある。本稿では,放射線の人体に対する影響やその生物学的線量評価法について概説し,放射線が実際にどの程度患者や術者に生物学的影響を与えているのかを論じる。
- 24 January 2022
- Published by Radiation Research Society in Radiation Research
- Vol. 197 (4) , 384-395
A Combination of Iohexol Treatment and Ionizing Radiation Exposure Enhances Kidney Injury in Contrast-Induced Nephropathy by Increasing DNA Damage
Contrast media has been shown to induce nephropathy (i.e., contrast-induced nephropathy) after various types of radiological examinations. The molecular mechanism of contrast-induced nephropathy has been unclear. In this study, we investigated the mechanism of contrast-induced nephropathy by examining the effects of combined treatment of contrast medium and ionizing radiation on kidney cells in vitro and kidney tissue in vivo. In human renal tubular epithelium cells, immunofluorescence analysis revealed that iohexol increased the numbers of radiation-induced γH2AX nuclear foci. The numbers of γH2AX nuclear foci remained high at 24 h, suggesting that some radiation-induced double-strand breaks remain unrepaired in the presence of iohexol. We established a mouse model of contrast-induced nephropathy, then showed that iohexol and ionizing radiation synergistically reduced renal function and induced double-strand breaks. Importantly, iohexol induced significant macrophage accumulation and oxidative DNA damage in the kidneys of contrast-induced nephropathy model mice in the absence of ionizing radiation; these effects were amplified by ionizing radiation. The results suggest that underlying inflammation and oxidative DNA damage caused by iohexol contribute to the enhancement of radiation-induced double-strand breaks, leading to contrast-induced nephropathy.
- 24 January 2022
- Published by Radiation Research Society in Radiation Research
- Vol. 197 (4) , 384-395
A Combination of Iohexol Treatment and Ionizing Radiation Exposure Enhances Kidney Injury in Contrast-Induced Nephropathy by Increasing DNA Damage
Contrast media has been shown to induce nephropathy (i.e., contrast-induced nephropathy) after various types of radiological examinations. The molecular mechanism of contrast-induced nephropathy has been unclear. In this study, we investigated the mechanism of contrast-induced nephropathy by examining the effects of combined treatment of contrast medium and ionizing radiation on kidney cells in vitro and kidney tissue in vivo. In human renal tubular epithelium cells, immunofluorescence analysis revealed that iohexol increased the numbers of radiation-induced γH2AX nuclear foci. The numbers of γH2AX nuclear foci remained high at 24 h, suggesting that some radiation-induced double-strand breaks remain unrepaired in the presence of iohexol. We established a mouse model of contrast-induced nephropathy, then showed that iohexol and ionizing radiation synergistically reduced renal function and induced double-strand breaks. Importantly, iohexol induced significant macrophage accumulation and oxidative DNA damage in the kidneys of contrast-induced nephropathy model mice in the absence of ionizing radiation; these effects were amplified by ionizing radiation. The results suggest that underlying inflammation and oxidative DNA damage caused by iohexol contribute to the enhancement of radiation-induced double-strand breaks, leading to contrast-induced nephropathy.
- Open Access
Distinctive nuclear zone for RAD51-mediated homologous recombinational DNA repair
Genome-based functions are inseparable from the dynamic higher-order architecture of the cell nucleus. In this context, the repair of DNA damage is coordinated by precise spatiotemporal controls that target and regulate the repair machinery required to maintain genome integrity. However, the mechanisms that pair damaged DNA with intact template for repair by homologous recombination (HR) without illegitimate recombination remain unclear. This report highlights the intimate relationship between nuclear architecture and HR in mammalian cells. RAD51, the key recombinase of HR, forms spherical foci in S/G 2 phases spontaneously. Using super-resolution microscopy, we show that following induction of DNA double-strand breaks RAD51 foci at damaged sites elongate to bridge between intact and damaged sister chromatids; this assembly occurs within bundle-shaped distinctive nuclear zones, requires interactions of RAD51 with various factors, and precedes ATP-dependent events involved the recombination of intact and damaged DNA. We observed a time-dependent transfer of single-stranded DNA overhangs, generated during HR, into such zones. Our observations suggest that RAD51-mediated homologous pairing during HR takes place within the distinctive nuclear zones to execute appropriate recombination.
Open AccessDistinctive nuclear zone for RAD51-mediated homologous recombinational DNA repair
Genome-based functions are inseparable from the dynamic higher-order architecture of the cell nucleus. In this context, the repair of DNA damage is coordinated by precise spatiotemporal controls that target and regulate the repair machinery required to maintain genome integrity. However, the mechanisms that pair damaged DNA with intact template for repair by homologous recombination (HR) without illegitimate recombination remain unclear. This report highlights the intimate relationship between nuclear architecture and HR in mammalian cells. RAD51, the key recombinase of HR, forms spherical foci in S/G 2 phases spontaneously. Using super-resolution microscopy, we show that following induction of DNA double-strand breaks RAD51 foci at damaged sites elongate to bridge between intact and damaged sister chromatids; this assembly occurs within bundle-shaped distinctive nuclear zones, requires interactions of RAD51 with various factors, and precedes ATP-dependent events involved the recombination of intact and damaged DNA. We observed a time-dependent transfer of single-stranded DNA overhangs, generated during HR, into such zones. Our observations suggest that RAD51-mediated homologous pairing during HR takes place within the distinctive nuclear zones to execute appropriate recombination.